Your Cart 0 Items | US$0.00
$ USD

Strategic Partners

Strategic Alliances

Genzyme Pharmaceuticals

Genzyme Pharmaceuticals

One of the world’s foremost biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Founded in Boston in 1981, Genzyme has grown from a small start-up to a diversified enterprise with annual revenues exceeding $3 billion and more than 9,000 employees in locations spanning the globe. With many established products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company’s products and services are focused on rare inherited disorders, kidney disease, orthopaedics, transplant, cancer, and diagnostic testing. Genzyme’s commitment to innovation continues today with a substantial research and development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need. For more information visit: www.genzymepharmaceuticals.com or www.peptidechain.com

PepScan Systems

PepScan Systems

Pepscan Systems is a privately held Dutch company that has longstanding know-how in surface chemistry, peptide synthesis and coupling chemistry. Furthermore, it has proprietary technologies for spatial organization of peptide-based molecules to improve their biological functions (CLIPS™ technology, Chemically Linked Peptides on Scaffolds). The company uses its technology both to enable the development of therapeutic vaccines and in the development of a line of peptide microarrays. For more information visit: www.pepscan.com

Pure protein

Pure Protein

Formed in Delaware in 1999, Pure Protein L.L.C. specializes in immunology tools for diagnostics, drug and vaccine development, and high-yield protein production. We have developed a unique method to clone and produce soluble HLA (sHLA) protein. This innovative method enables production of large quantities of immune surveillance proteins, providing powerful insight into the workings of diseased cells. Our proprietary sHLA production method generates pure, single species antigens and greatly increases yield, while still maintaining correct processing. Applications of the Pure Protein platform include immunology research, transplant and transfusion medicine, and vaccine development. The Pure Protein platform was originally discovered and patented by Dr. Hildebrand at the University of Oklahoma.
For more information visit: www.pureproteinllc.com

Glycosyn

Glycosyn

GlycoSyn was established in 2003 to complement an existing and successful drug discovery platform with downstream process development, non-GMP and GMP manufacture of active pharmaceutical ingredients (APIs). GlycoSyn has successfully delivered development and manufacturing services to international clients involving API’s ranging in nature from flat earth small molecules to dendrimers and complex oligosaccharides. For more information visit: www.glycosyn.com

Home | Custom Peptides | Peptide Libraries | Catalogue | Resources | About Us | FAQs | Contact Us | Terms & Conditions | Web Design Bliss Media
Copyright 2009 Mimotopes. All rights reserved.